Retirement Guys Formula LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 72.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,511 shares of the healthcare conglomerate's stock after buying an additional 3,998 shares during the quarter. UnitedHealth Group comprises about 1.1% of Retirement Guys Formula LLC's investment portfolio, making the stock its 21st biggest holding. Retirement Guys Formula LLC's holdings in UnitedHealth Group were worth $2,967,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock valued at $4,257,131,000 after purchasing an additional 196,696 shares in the last quarter. Finally, Nuveen LLC bought a new stake in UnitedHealth Group in the 1st quarter worth about $3,846,764,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Bank of America lifted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research note on Friday, September 12th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Stock Performance
Shares of UNH opened at $351.87 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $318.68 billion, a price-to-earnings ratio of 15.25, a PEG ratio of 2.27 and a beta of 0.45. The business has a 50-day simple moving average of $298.81 and a two-hundred day simple moving average of $362.32.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the prior year, the company posted $6.80 earnings per share. The company's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.